Assessment of Hepatocellular Carcinoma Response to
Journal
Radiology. Imaging cancer
ISSN: 2638-616X
Titre abrégé: Radiol Imaging Cancer
Pays: United States
ID NLM: 101765309
Informations de publication
Date de publication:
24 07 2020
24 07 2020
Historique:
received:
21
11
2019
revised:
13
04
2020
accepted:
28
04
2020
entrez:
18
8
2020
pubmed:
18
8
2020
medline:
18
8
2020
Statut:
epublish
Résumé
To quantify diffusion and perfusion changes in hepatocellular carcinoma (HCC) induced by yttrium 90 ( Institutional review board approval was obtained for this prospective study (clinical trial registry NCT01871545). Twenty-four participants with HCC (mean age, 69 years ± 9 [standard deviation], 18 men) underwent multiparametric MRI, including IVIM DWI and gadoxetic acid DCE MRI before ( Twenty-five HCCs were analyzed (mean size, 3.6 cm ± 1.9). Radioembolization resulted in significantly decreased perfusion (DCE MRI arterial flow, Diffusion and perfusion MRI can be used to evaluate the response of HCC to radioembolization. Pretreatment DCE MRI histogram parameters may be useful for radioembolization treatment stratification.
Identifiants
pubmed: 32803165
doi: 10.1148/rycan.2020190094
pmc: PMC7398117
doi:
Substances chimiques
Contrast Media
0
Yttrium Radioisotopes
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Pagination
e190094Subventions
Organisme : NIBIB NIH HHS
ID : U24 EB028980
Pays : United States
Informations de copyright
2020 by the Radiological Society of North America, Inc.
Références
Liver Int. 2015 Mar;35(3):1036-47
pubmed: 24750853
Radiology. 2018 Dec;289(3):816-830
pubmed: 30251931
Magn Reson Med. 2014 Jan;71(1):411-20
pubmed: 23408505
Radiology. 2013 Mar;266(3):920-9
pubmed: 23220895
Radiology. 2017 Jun;283(3):895-905
pubmed: 27930089
J Vasc Interv Radiol. 2014 Jul;25(7):1075-84
pubmed: 24861664
Eur Radiol. 2019 Oct;29(10):5403-5414
pubmed: 30877465
Sci Rep. 2017 May 26;7(1):2452
pubmed: 28550313
AJR Am J Roentgenol. 2017 Nov;209(5):W263-W276
pubmed: 29072955
Gastroenterology. 2016 Dec;151(6):1155-1163.e2
pubmed: 27575820
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Abdom Imaging. 2015 Aug;40(6):1471-80
pubmed: 25412868
J Hepatol. 2011 Dec;55(6):1309-16
pubmed: 21703196
J Magn Reson Imaging. 2019 Jun;49(7):e101-e121
pubmed: 30451345
Cancer Imaging. 2014 Jan 03;13(4):645-57
pubmed: 24434228
J Vasc Interv Radiol. 2005 Dec;16(12):1627-39
pubmed: 16371529
J Vasc Interv Radiol. 2016 Sep;27(9):1320-1328
pubmed: 27402526
Korean J Radiol. 2018 Mar-Apr;19(2):209-222
pubmed: 29520178
Eur Radiol. 2019 Jan;29(1):213-223
pubmed: 29922932
J Magn Reson Imaging. 2015 Jan;41(1):149-56
pubmed: 24415565
Magn Reson Imaging. 2019 Oct;62:78-86
pubmed: 31247250
J Magn Reson Imaging. 2002 Oct;16(4):407-22
pubmed: 12353256
Hepatology. 2010 Nov;52(5):1741-9
pubmed: 21038413
Radiology. 2014 Mar;270(3):758-67
pubmed: 24475811
J Hepatol. 2017 Dec;67(6):1213-1221
pubmed: 28823713
J Magn Reson Imaging. 2016 Oct;44(4):856-64
pubmed: 26919327
Transplant Proc. 2019 Sep;51(7):2391-2396
pubmed: 31474296
Cardiovasc Intervent Radiol. 2016 Mar;39(3):400-8
pubmed: 26216725
Cancer Imaging. 2019 May 29;19(1):29
pubmed: 31142363
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
Radiology. 2012 Jun;263(3):874-83
pubmed: 22623698
J Magn Reson Imaging. 2017 Sep;46(3):820-830
pubmed: 28276105
Radiographics. 2017 Nov-Dec;37(7):1994-2017
pubmed: 29131761
EJNMMI Phys. 2018 Nov 2;5(1):22
pubmed: 30386924
Hepatology. 2014 Jul;60(1):192-201
pubmed: 24691943
J Hepatol. 2017 Jun;66(6):1166-1172
pubmed: 28131794
Clin Cancer Res. 2015 Apr 15;21(8):1951-61
pubmed: 25248380
Eur J Cancer. 2013 Mar;49(4):826-34
pubmed: 22995582
Magn Reson Imaging Clin N Am. 2010 Aug;18(3):383-402, ix
pubmed: 21094446
Radiology. 1988 Aug;168(2):497-505
pubmed: 3393671
Am J Clin Oncol. 2011 Aug;34(4):422-31
pubmed: 20622645
World J Gastroenterol. 2013 Nov 14;19(42):7316-26
pubmed: 24259963